High platelet count multiplies risk following renal cell carcinoma treatment.
出版信息
Urol Nurs. 2001 Jun;21(3):224-5.
PMID:11998657
Abstract
摘要
相似文献
1
High platelet count multiplies risk following renal cell carcinoma treatment.肾细胞癌治疗后血小板计数升高会增加风险。
Urol Nurs. 2001 Jun;21(3):224-5.
2
Editorial comment on: Platelet count and preoperative haemoglobin do not significantly increase the performance of established predictors of renal cell carcinoma-specific mortality.关于“血小板计数和术前血红蛋白并不能显著提高肾细胞癌特异性死亡率既定预测指标的效能”的编辑评论
Eur Urol. 2007 Nov;52(5):1436-7. doi: 10.1016/j.eururo.2007.03.037.
3
Prognostic significance of thrombocytosis in renal cell carcinoma patients.血小板增多症在肾细胞癌患者中的预后意义。
Int J Urol. 2004 Jun;11(6):364-7. doi: 10.1111/j.1442-2042.2004.00808.x.
4
Clinical significance of platelet count in patients with renal cell carcinoma.肾细胞癌患者血小板计数的临床意义
Urol Int. 2007;79(2):111-6. doi: 10.1159/000106322.
5
Thrombocytosis and hematocrit as prognostic factors in renal carcinoma.血小板增多症和血细胞比容作为肾癌的预后因素。
Arch Esp Urol. 2011 Nov;64(9):883-90.
6
Platelet count and preoperative haemoglobin do not significantly increase the performance of established predictors of renal cell carcinoma-specific mortality.血小板计数和术前血红蛋白并不能显著提高已确立的肾细胞癌特异性死亡率预测指标的效能。
Eur Urol. 2007 Nov;52(5):1428-36. doi: 10.1016/j.eururo.2007.03.036. Epub 2007 Mar 28.
7
Impact of thrombocytosis and C-reactive protein elevation on the prognosis for patients with renal cell carcinoma.血小板增多症和C反应蛋白升高对肾细胞癌患者预后的影响。
Int J Urol. 2006 Nov;13(11):1365-70. doi: 10.1111/j.1442-2042.2006.01563.x.
8
Editorial comment.编者按。
J Urol. 2010 Feb;183(2):492. doi: 10.1016/j.juro.2009.10.063. Epub 2009 Dec 14.
9
Prognostic value of thrombocytosis in renal cell carcinoma.血小板增多症在肾细胞癌中的预后价值。
J Urol. 2006 Mar;175(3 Pt 1):859-63. doi: 10.1016/S0022-5347(05)00526-4.
10
Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma.血小板增多症作为转移性肾细胞癌患者生存的预后因素。
Cancer. 2006 Oct 15;107(8):1793-800. doi: 10.1002/cncr.22237.
Zotero 插件